TGF-β2 has been implicated in the development of a variety of cancers, including lung cancer, gastrointestinal stromal cancer, pancreatic cancer, breast cancer, glioma, melanoma, and so on [107,108,109]. Here, TGFB2 is linked to breast carcinoma.